NEW YORK (GenomeWeb) – Insilico Medicine said this week that it will integrate unspecified data assets as well as the staff of InSilico Screen, a Belgian bioinformatics company that provides tools for dynamic signaling modelling and scalable molecular simulations.

Under the terms of the agreement, InSilico Screen Founder and CEO Quentin Vanhaelen will join Insilico Medicine as the head of the so-called "almost human" team. He will split his time between Baltimore, where InSilico Medicine has an office, and Brussels, where InSilico Screen is located.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.